title: Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma.
abstract: Pseudoexfoliation (PEX) syndrome, which is an age-related, generalized elastotic matrix process, currently represents the most common identifiable risk factor for open-angle glaucoma. Dysregulated expression of proinflammatory cytokines has been implicated in the initiation of various fibrotic disorders and in the pathophysiology of glaucoma. Here we investigated the presence, expression, regulation, and functional significance of proinflammatory cytokines in eyes with early and late stages of PEX syndrome/glaucoma in comparison with normal and glaucomatous control eyes using multiplex bead analysis, immunoassays, real-time PCR, Western blotting, immunohistochemistry, and cell culture models. Early stages of PEX syndrome were characterized by approximately threefold (P < 0.005) elevated interleukin (IL)-6 and IL-8 levels in the aqueous humor and a concomitant approximately twofold (P < 0.001) increase in mRNA expression levels in anterior segment tissues as compared with controls. In contrast, late stages of PEX syndrome/glaucoma did not differ significantly from controls. IL-6, IL-6 receptor, and phospho-signal transducer and activator of transcription 3 could be mainly localized to walls of iris vessels and to the nonpigmented epithelium of ciliary processes. IL-6 and IL-8 were significantly up-regulated by ciliary epithelial cells in response to hypoxia or oxidative stress in vitro, whereas IL-6, but not IL-8, induced the expression of transforming growth factor-beta1 and elastic fiber proteins. These findings support a role for a stress-induced, spatially, and temporally restricted subclinical inflammation in the onset of the fibrotic matrix process characteristic of PEX syndrome/glaucoma.
authors.affiliation: Department of Ophthalmology, University of Erlangen-Nürnberg, Schwabachanlage 6, D-91054 Erlangen, Germany. matthias.zenkel@uk-erlangen.de
authors.forename: Matthias
authors.initials: M
authors.lastname: Zenkel
authors.forename: Piotr
authors.initials: P
authors.lastname: Lewczuk
authors.forename: Anselm
authors.initials: A
authors.lastname: Jünemann
authors.forename: Friedrich E
authors.initials: FE
authors.lastname: Kruse
authors.forename: Gottfried O H
authors.initials: GO
authors.lastname: Naumann
authors.forename: Ursula
authors.initials: U
authors.lastname: Schlötzer-Schrehardt
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001082:Aqueous Humor / Q000276:immunology; D002460:Cell Line; D016207:Cytokines / Q000235:genetics / Q000276:immunology*; D017889:Exfoliation Syndrome / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D005109:Extracellular Matrix / Q000378:metabolism / Q000473:pathology*; D005123:Eye / Q000033:anatomy & histology / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005902:Glaucoma, Open-Angle / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics / Q000276:immunology; D016209:Interleukin-8 / Q000235:genetics / Q000276:immunology; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data
chemical_list: D016207:Cytokines; D015850:Interleukin-6; D016209:Interleukin-8
references.citation: J Gerontol A Biol Sci Med Sci. 2006 Jun;61(6):575-84
references.pmid: 16799139
references.citation: Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1447-57
references.pmid: 17389470
references.citation: Am J Ophthalmol. 2006 May;141(5):921-937
references.pmid: 16678509
references.citation: Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):572-81
references.pmid: 16677101
references.citation: Respir Res. 2002;3:1
references.pmid: 11806836
references.citation: Br J Ophthalmol. 2003 Mar;87(3):353-6
references.pmid: 12598453
references.citation: Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4251-9
references.pmid: 16249505
references.citation: Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10061-5
references.pmid: 7694279
references.citation: Invest Ophthalmol Vis Sci. 2000 Feb;41(2):352-61
references.pmid: 10670462
references.citation: Br J Dermatol. 2009 Aug;161(2):237-48
references.pmid: 19438433
references.citation: Hepatology. 2006 Dec;44(6):1487-501
references.pmid: 17133487
references.citation: Ophthalmic Res. 1995;27 Suppl 1:136-42
references.pmid: 8577452
references.citation: Rev Esp Enferm Dig. 2005 Aug;97(8):575-95
references.pmid: 16266225
references.citation: Exp Eye Res. 2001 Dec;73(6):765-80
references.pmid: 11846508
references.citation: Am J Ophthalmol. 2006 Jul;142(1):192-4
references.pmid: 16815285
references.citation: Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2796-801
references.pmid: 19182256
references.citation: Clin Immunol Immunopathol. 1992 Dec;65(3):278-85
references.pmid: 1451330
references.citation: J Clin Invest. 2001 Jun;107(12):1529-36
references.pmid: 11413160
references.citation: Endocrinology. 1992 Aug;131(2):710-4
references.pmid: 1639018
references.citation: Am J Pathol. 2008 Dec;173(6):1724-35
references.pmid: 18974306
references.citation: Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5558-66
references.pmid: 18055805
references.citation: Stem Cells. 1994 May;12(3):262-77
references.pmid: 8075593
references.citation: Invest Ophthalmol Vis Sci. 2002 May;43(5):1475-87
references.pmid: 11980863
references.citation: J Invest Dermatol. 1991 Oct;97(4):686-92
references.pmid: 1940439
references.citation: Connect Tissue Res. 2007;48(5):263-70
references.pmid: 17882702
references.citation: Prog Retin Eye Res. 2004 Jul;23(4):435-48
references.pmid: 15219876
references.citation: J Rheumatol. 1998 Feb;25(2):308-13
references.pmid: 9489824
references.citation: Science. 2007 Sep 7;317(5843):1397-400
references.pmid: 17690259
references.citation: J Clin Invest. 2001 Jun;107(12):1501-2
references.pmid: 11413155
references.citation: J Cell Physiol. 1989 Nov;141(2):243-52
references.pmid: 2553750
references.citation: Invest Ophthalmol Vis Sci. 2007 May;48(5):2203-7
references.pmid: 17460280
references.citation: Nat Med. 2001 Mar;7(3):304-9
references.pmid: 11231628
references.citation: Arch Ophthalmol. 2001 Jul;119(7):1023-31
references.pmid: 11448324
references.citation: Arch Ophthalmol. 1987 Aug;105(8):1076-82
references.pmid: 3632416
references.citation: Biochem Biophys Res Commun. 2005 Dec 2;337(4):1229-36
references.pmid: 16229816
references.citation: Invest Ophthalmol Vis Sci. 2006 May;47(5):1982-90
references.pmid: 16639006
references.citation: J Glaucoma. 2008 Aug;17(5):378-85
references.pmid: 18703948
references.citation: Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2627-32
references.pmid: 10509659
references.citation: Surv Ophthalmol. 2001 Jan-Feb;45(4):265-315
references.pmid: 11166342
references.citation: Cornea. 1997 Sep;16(5):580-7
references.pmid: 9294693
references.citation: Cytokine. 2000 Jun;12(6):671-6
references.pmid: 10843743
references.citation: Ger J Ophthalmol. 1994 May;3(3):148-53
references.pmid: 8038683
references.citation: Arch Dermatol Res. 2003 Jan;294(10-11):433-7
references.pmid: 12563540
references.citation: Mol Vis. 2009;15:326-34
references.pmid: 19209241
references.citation: J Ocul Biol Dis Infor. 2009 Jun;2(2):78-83
references.pmid: 19672464
references.citation: Mol Vis. 2007 Dec 17;13:2282-8
references.pmid: 18199969
references.citation: Am J Respir Cell Mol Biol. 1998 Oct;19(4):653-61
references.pmid: 9761763